companydata.dkHEI Therapeutics ApS: Financial statements 2024
CVR: 42613207
HEI Therapeutics ApS (CVR 42613207) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,762,455 and a net result of DKK -12,890,414 compared with DKK -381,736 the year before. That is a decrease of 55.2% compared with the year before. Equity amounted to DKK -13,516,567. The company had 5 employees in the financial year.
- Gross Profit
- 1,762,455 kr.
- Profit/Loss
- -12,890,414 kr.
- Equity
- -13,516,567 kr.
- Total Assets
- 2,359,216 kr.
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.8 mio. | -12.9 mio. | -13.5 mio. | 5 |
| 2023 | - | 3.9 mio. | -382 t. | -626 t. | 5 |
Events in 2024
HEI Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK 3,935,885, and the net result was DKK -381,736.
About HEI Therapeutics ApS
HEI Therapeutics ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2021. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kenneth Berg. The company is owned by HOGDALL HOLDING ApS, WISV Holding ApS and JKimer Holding ApS. In 2024, the company reported a gross profit of DKK 1,762,455 and a net result of DKK -12,890,414 compared with DKK -381,736 the year before. Equity amounted to DKK -13,516,567.